Key Trends & Opportunities in Life Sciences and Healthcare Investing -
The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more
12/9/2022
/ Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
McDermott was delighted to partner with the BVCA (British Venture Capital Association) on its recent virtual Sector Forum Series: Healthcare event. The event gathered industry experts – from entrepreneurs, to investors and...more
12/3/2020
/ Capital Markets ,
Digital Health ,
Entrepreneurs ,
EU ,
Healthcare ,
Investment ,
Investment Adviser ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
UK ,
Venture Capital
Following the wider outbreak of the coronavirus (COVID-19) around the world, radical—and sometimes controversial—actions have been and are further expected to be taken by national, federal and local governments and...more
3/16/2020
/ Acquisitions ,
Business Interruption ,
Capital Markets ,
Commercial Insurance Policies ,
Contract Terms ,
Coronavirus/COVID-19 ,
Corporate Financing ,
Corporate Governance ,
Crisis Management ,
Debt Restructuring ,
Emergency Management Plans ,
Employer Responsibilities ,
Health Insurance ,
Healthcare Facilities ,
Life Sciences ,
Mergers ,
Portfolio Companies ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Regulatory Standards ,
Risk Assessment ,
Risk Mitigation ,
Supply Chain